SpaceX IPO Poses Hidden Risks for Broader Market

AOL.com reported Monday that SpaceX’s anticipated IPO carries significant structural risks for broader equity markets, with analysts warning of liquidity pressure, forced selling, and dangerous levels of index concentration.

SpaceX IPO Risk and the Cash Problem

SpaceX is expected to raise roughly $75 billion when it goes public on June 12. That capital has to come from somewhere. The problem is that investors have very little dry powder available. Bank of America data shows its private wealth clients hold cash at a record low of just 9.9% of their portfolios, while stocks account for a record 66% of their holdings. Funding new SpaceX purchases will likely mean selling existing positions elsewhere, creating downward pressure across parts of the market.

Bob Doll, CEO of Crossmark Global Investments and former equities chief at BlackRock, told Business Insider that growth-factor stocks could face the first wave of selling pressure. He noted the behaviour of tech enthusiasts is not always logical. Some may sell defensive holdings like consumer staples rather than trimming existing tech positions, making the eventual selling pattern genuinely unpredictable.

Also Read: What the IPO Boom Says About Market Froth

Index Reweighting Creates a Second Wave of Risk

Beyond the initial IPO demand, MSCI research warns that adding SpaceX and other large firms to the Nasdaq 100 and similar indexes will force mechanical reweighting across entire sectors. As tech’s share of those indexes grows, consumer discretionary and healthcare will shrink proportionally. Index funds must then sell down those sectors automatically. Within tech itself, MSCI estimates the largest resulting outflows will hit Nvidia, Apple, and Microsoft directly.

A Market Already Stretched Thin

The concentration story predates this IPO cycle. AI megacaps are approaching a position where they could represent roughly half of the entire S&P 500. Asher Regovy, chief investment officer at Magnifina, has warned that such concentration leaves the index acutely vulnerable to a single shock event, such as a disappointing earnings release triggering cascading moves across correlated stocks.

Doll himself is not alarmed yet. He argues tech valuations remain reasonable and any liquidity disruption will be brief. His current positioning blends defensive stocks with AI-exposed names, favouring firms with strong return on equity. For investors seeking to reduce concentration exposure directly, UBS recently advised clients to broaden internationally, pointing to Japanese, Chinese, and Swiss equities, alongside European consumer discretionary and global healthcare.

Read Next: Fed Policy Uncertainty Keeps Markets on Edge